tiprankstipranks
Trending News
More News >
Matsumoto Yushiseiyaku Co., Ltd. (JP:4365)
:4365
Japanese Market
Advertisement

Matsumoto Yushiseiyaku Co., Ltd. (4365) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4365

Matsumoto Yushiseiyaku Co., Ltd.

(4365)

Select Model
Select Model
Select Model
Outperform 79 (OpenAI - 4o)
Rating:79Outperform
Price Target:
Matsumoto Yushiseiyaku Co., Ltd. is well-positioned in the specialty chemicals industry, benefiting from strong financial health, solid profitability, and an attractive valuation. However, the lack of recent cash flow data is a notable concern. Technical indicators suggest the stock is fairly valued with balanced trading momentum.

Matsumoto Yushiseiyaku Co., Ltd. (4365) vs. iShares MSCI Japan ETF (EWJ)

Matsumoto Yushiseiyaku Co., Ltd. Business Overview & Revenue Model

Company DescriptionMatsumoto Yushiseiyaku Co., Ltd. (4365) is a Japanese company operating in the chemical and pharmaceutical sectors. The company specializes in the development, manufacturing, and distribution of chemical products, including fine chemicals and pharmaceutical ingredients. With a focus on innovation and quality, Matsumoto Yushiseiyaku serves various industries, providing essential components for pharmaceuticals, cosmetics, and other chemical-based applications.
How the Company Makes MoneyMatsumoto Yushiseiyaku Co., Ltd. generates revenue primarily through the sale of its chemical products and pharmaceutical ingredients. The company supplies these products to various industries, including pharmaceuticals and cosmetics, which rely on high-quality chemical components for their products. Additionally, the company may engage in collaborations and partnerships with other firms to enhance its product offerings and market reach, further contributing to its revenue streams. The company's focus on research and development ensures a steady pipeline of innovative products, catering to the evolving needs of its clients and maintaining its competitive edge in the market.

Matsumoto Yushiseiyaku Co., Ltd. Financial Statement Overview

Summary
Matsumoto Yushiseiyaku Co., Ltd. shows strong financial performance with robust profitability and a solid balance sheet. The income statement reflects strong profit margins and revenue growth, while the balance sheet shows zero debt and a high equity ratio. However, the cash flow analysis is mixed due to a lack of reported TTM cash flows, which raises concerns despite previous positive cash flow metrics.
Income Statement
85
Very Positive
Matsumoto Yushiseiyaku Co., Ltd. demonstrates strong profitability with a consistent increase in gross and net profit margins. The TTM gross profit margin is approximately 32.39%, and the net profit margin is 18.21%, indicating effective cost management and robust earnings. Revenue growth is notable, with a 12.86% increase from 2022 to 2023 and 2.91% from 2023 to 2024. The company's EBIT and EBITDA margins for TTM are also strong at 22.03% and 26.09%, respectively, reflecting operational efficiency.
Balance Sheet
92
Very Positive
The balance sheet of Matsumoto Yushiseiyaku is exceptionally strong, with zero debt and a high equity ratio. The company has no debt, resulting in a debt-to-equity ratio of 0, which is beneficial for financial stability. The equity ratio is impressive at approximately 83.20% for TTM, indicating a solid capital structure and minimal financial risk. The return on equity (ROE) is also strong at 9.87%, demonstrating effective use of shareholder capital.
Cash Flow
70
Positive
Cash flow analysis shows mixed results. While the company had substantial free cash flow generation in 2023, the TTM data indicates zero reported cash flows, likely due to reporting issues or changes in accounting practices. In the previous year, the free cash flow to net income ratio was approximately 0.84, suggesting efficient cash conversion. However, the lack of TTM cash flow data is a concern that needs clarification.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue41.96B43.13B41.53B39.63B37.25B29.61B
Gross Profit12.71B13.69B12.96B12.02B9.81B7.61B
EBITDA10.49B10.80B11.70B11.12B8.70B5.73B
Net Income5.65B6.83B7.50B7.25B5.49B3.43B
Balance Sheet
Total Assets94.66B95.19B89.51B79.19B76.21B68.65B
Cash, Cash Equivalents and Short-Term Investments47.45B49.04B51.06B45.88B43.66B40.49B
Total Debt0.000.000.000.000.000.00
Total Liabilities13.14B13.82B14.18B12.72B12.82B10.31B
Stockholders Equity79.65B79.40B73.36B64.69B63.23B58.20B
Cash Flow
Free Cash Flow0.006.59B6.31B4.98B3.87B4.23B
Operating Cash Flow0.007.77B7.37B5.42B4.33B5.04B
Investing Cash Flow0.00-9.05B-17.87B144.00M-685.00M-764.00M
Financing Cash Flow0.00-1.24B-1.02B-5.93B-983.00M-987.00M

Matsumoto Yushiseiyaku Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price18990.00
Price Trends
50DMA
19654.60
Negative
100DMA
19294.30
Negative
200DMA
18459.32
Positive
Market Momentum
MACD
-84.08
Positive
RSI
29.59
Positive
STOCH
45.24
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4365, the sentiment is Negative. The current price of 18990 is below the 20-day moving average (MA) of 19742.50, below the 50-day MA of 19654.60, and above the 200-day MA of 18459.32, indicating a neutral trend. The MACD of -84.08 indicates Positive momentum. The RSI at 29.59 is Positive, neither overbought nor oversold. The STOCH value of 45.24 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4365.

Matsumoto Yushiseiyaku Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
¥61.45B9.752.11%-1.66%-29.18%
79
Outperform
¥70.03B5.943.16%3.55%214.69%
73
Outperform
€70.89B14.1510.57%2.16%15.12%40.72%
73
Outperform
¥47.94B9.454.83%0.10%
71
Outperform
¥59.37B13.753.37%5.45%25.48%
69
Neutral
¥65.60B14.034.21%0.32%-43.10%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4365
Matsumoto Yushiseiyaku Co., Ltd.
18,990.00
1,761.56
10.22%
JP:4187
Osaka Organic Chemical Industry Ltd.
3,200.00
273.31
9.34%
JP:4008
Sumitomo Seika Chemicals Co., Ltd.
4,750.00
-51.47
-1.07%
JP:4078
Sakai Chemical Industry Co., Ltd.
2,844.00
318.43
12.61%
JP:4116
Dainichiseika Color & Chemicals Mfg.Co., Ltd.
3,895.00
1,096.26
39.17%
JP:4362
Nippon Fine Chemical Co., Ltd.
2,500.00
231.22
10.19%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 03, 2025